Michael P. Thirlwell

Author

Also Known As

Laura Biganzoli, M P Thirlwell, M Thirlwell, M. P. Thirlwell, M. Thirlwell, M.P. Thirlwell, Maureen Trudeau, Michael P Thirlwell, Michael P. Thirlwell, Michael Thirlwell

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Montreal General Hospital McGill University Health Centre McGill University Ottawa Hospital Purdue Pharma (Canada)

About

Michael P. Thirlwell is an author at Montreal General Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	19	1.1K
2	Health Sciences	7	7	625
3	Gastroenterology	5	5	250
4	Anesthesia	2	2	141
5	Public Health	1	1	39

Michael P. Thirlwell

Publications

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial Stephen Johnston, Shannon Puhalla, Duncan Wheatley, Journal of Clinical Oncology	2018	224
Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. Michael Perloff, Gerson Lesnick, A. E. Korzun, Journal of Clinical Oncology Surgical OncologyThirteen Evaluable PatientsCombination ChemotherapyRadiation TherapyCombined Modality Therapy	1988	194
Prevention and Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer: A Consensus Statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea Jean A. Maroun, Lowell Anthony, Normand Blais, Current Oncology	2007	158
Randomized Trial of 3-Hour Versus 24-Hour Infusion of High-Dose Paclitaxel in Patients With Metastatic or Locally Advanced Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-26 Roy E. Smith, Ann Brown, Eleftherios P. Mamounas, Journal of Clinical Oncology	1999	155
Hepatic malignancies: improved treatment with intraarterial Y-90. Milton J. Herba, F F Illescas, Michael P. Thirlwell, Radiology Surgical OncologyHepatologyIslet Cell TumorMedicineLiver Physiology	1988	141
Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients Michael P. Thirlwell, Paul A. Sloan, Jean A. Maroun, Cancer Pain MedicineMorphine AnalysisPharmacotherapyCancer PatientsPlasma Morphine Concentrations	1989	112
Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial Lorenzo Ferri, Steven Ades, Thierry Alcindor, Annals of Oncology Advanced EsophagealEsophageal CancerGastrointestinal OncologyMedicineSurgery	2011	102
Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial CH Barcenas, Sara A. Hurvitz, Jack A. Di Palma, Annals of Oncology	2020	102
Abstract S1-03: Primary results from BETH, a phase 3 controlled study of adjuvant chemotherapy and trastuzumab ± bevacizumab in patients with HER2-positive, node-positive or high risk node-negative breast cancer DJ Slamon, SM Swain, Marc Buyse, Cancer Research Breast OncologyPrimary ResultsImmunologyAdjuvant ChemotherapyPathology	2013	92
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain Helen Hays, Neil A. Hagen, Michael P. Thirlwell, Cancer	1994	77

Page 1